ALKemist Bio

📍 Turin, Italy🗓 Founded 2023👥 5 employees💰 Last funded Feb 2024
Biotechnology Research
LinkedIn
At ALKemist Bio we are developing TCR-T cells that possess the ability to specifically target ALK antigens found on ALK-positive cancer cells, primarily focusing on non-small cell lung cancer patients. By harnessing the power of the immune system and engineering T cells to precisely recognize and combat these cancerous cells, we aim to pave the way for more effective treatments aiming at improving the standard of care.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
2
Frequently asked questions
Who invested in ALKemist Bio?
ALKemist Bio has 2 investors on record on gritt.io, including 2 early-stage backers.
When did ALKemist Bio last raise funding?
The most recent investment in ALKemist Bio recorded on gritt.io was in February 2024.
When was ALKemist Bio founded?
ALKemist Bio was founded in 2023.
What industry is ALKemist Bio in?
ALKemist Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ALKemist Bio based?
ALKemist Bio is headquartered in Turin, Italy.